Cheri Silverstein Fadlon,
Assistant Professor of Internal Medicine
College of Osteopathic Medicine of the Pacific
Dr. Silverstein Fadlon completed her undergraduate education at Princeton University in Princeton, NJ, where she earned an AB in molecular biology and studied genomic imprinting in the laboratory of Shirley Tilghman, a Howard Hughes Medical Institute investigator and later President of the university. Dr. Silverstein Fadlon then earned a Dean’s Academic Excellence scholarship to the Rutgers New Jersey Medical School. Dr. Silverstein Fadlon completed residency training in Internal Medicine at Vanderbilt University in Nashville, TN. After residency, Dr. Silverstein Fadlon remained at Vanderbilt for two additional years as a Clinical Instructor and Clinical Research Fellow in the laboratory of Douglas Sawyer. During this time, she ran an observational study on cardiotoxicity in breast cancer therapy, helped to found a Center for Inherited Heart Disease and conducted registry based research on outcomes in heart transplantation, for which she was a finalist for the International Society of Heart and Lung Transplantation Philip K. Caves award. Dr. Silverstein Fadlon then moved here to Southern California where she completed a fellowship in Cardiovascular at University of California Los Angeles. While at UCLA, Dr. Silverstein Fadlon also completed Master of Science of Clinical Research and studied the use of non-traditional patient report registries.
Dr. Silverstein Fadlon joined Western University of Health Sciences and the Western Diabetes Institute after completing her fellowship in 2013. She currently teaches in the Cardiovascular System in the second year curriculum and conducts clinical research through the Western Diabetes Institute Integrated Practice Unit. She is interested in assessing the effect of the integrated practice model on cardiovascular outcomes in patients with diabetes.